NCT02811783 2022-10-28
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Elorac, Inc.
Phase 3 Terminated
Elorac, Inc.
Medical University of Graz
University Hospital, Brest
Boston University
University of Minnesota